Drug class
Dibenzoxazepine antipsychotic; dopamine and serotonin receptor antagonist
Mechanism of action
Acts as an antagonist at central dopamine and serotonin receptors, including D2 and 5-HT2A receptors. The precise mechanism responsible for clinical antipsychotic effects is not fully established.
General use cases
- Treatment of schizophrenia with oral formulations.
- Acute treatment of agitation associated with schizophrenia or bipolar I disorder with the inhaled formulation, where authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
